| Structure |
Chemical Name |
CAS |
MF |
 |
Trelagliptin Impurity 41 |
|
|
 |
Brivaracetam Impurity 10 |
60559-16-2 |
C10H20O2 |
 |
N-Methyl Iso Desloratadine |
183198-48-3 |
C20H21ClN2 |
 |
(R)-2-((3-methyl-6-(3-((1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
|
C23H25N7O4 |
 |
Peramivir Impurity 26 |
|
|
 |
Oseltamivir Impurity 32 |
|
|
 |
Oseltamivir Impurity 46 |
|
|
 |
4-Methoxy-5-(3-Morpholinopropoxy)-2-nitrobenzaMide |
861453-16-9 |
C15H21N3O6 |
 |
Empagliflozin Impurity 74 |
|
|
 |
3-ヒドロキシフェニルトリメチルアンモニウムヨージド |
2498-27-3 |
C9H14INO |
 |
Rupatadine Impurity B |
156523-04-5 |
C26H24ClN3O |
![EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4S)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]-](/CAS/GIF/1255529-25-9.gif) |
EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4S)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- |
1255529-25-9 |
C24H30ClN7O4S |
 |
4-(6-ブロモピリジン-3-イル)ピペラジン-1-カルボン酸TERT-ブチル |
412348-27-7 |
C14H20BrN3O2 |
 |
TYRPHOSTIN AG 1290 |
160391-70-8 |
C10H6N2O6 |
 |
Tolvaptan dehydroxylated impurity |
|
|
 |
Butyphthalide impurity 51 |
|
|
 |
Linagliptin Impurity K |
1638744-06-5 |
C25H29BrN8O2 |
![N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-1-piperazineacetamide](/CAS/20200331/GIF/1393717-45-7.gif) |
N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-1-piperazineacetamide |
1393717-45-7 |
C24H33N3O4 |
 |
イオペントール |
89797-00-2 |
C20H28I3N3O9 |
 |
1,4-ジトシル-1,4-ジアゼパン |
5769-35-7 |
C19H24N2O4S2 |
 |
Edoxaban Impurity 39 |
2081883-55-6 |
C14H27N3O3 |
 |
AzithroMycin iMpurity |
194809-66-0 |
C37H69BN2O13 |
 |
Butyphthalide impurity 48 |
|
|
 |
Parecoxib Impurity F |
|
|
 |
Cabozantinib Impurity 49 |
190728-26-8 |
C17H14N2O5 |
 |
Diroxide Impurity 4 |
|
|
 |
951313-25-0 |
951313-25-0 |
C25H33N3O6 |
 |
Posaconazole Impurity 61 |
|
|
 |
Afatinib impurity 47 |
|
|
 |
1H-Indazole, 4,5-dichloro- |
1020243-02-0 |
C7H4Cl2N2 |
 |
(3R,4R)-N,4-dimethyl-piperidin-3-amine |
1354469-76-3 |
C7H16N2 |
 |
3-(3-メチルベンゾイル)-1,1,1-トリフルオロアセトン |
53764-99-1 |
C11H9F3O2 |
 |
Sitagliptin N-Phoshate IMpurity |
1351498-25-3 |
C16H16F6N5O4P |
 |
WIXOVOWSUCEDGS-UHFFFAOYSA-N |
1346603-05-1 |
C15H20O5 |
 |
Tocopherol Impurity 1 |
3808-26-2 |
C29H48O2 |
 |
BAUCJPGULMYPTE-UHFFFAOYSA-N |
2097683-67-3 |
C24H29NO4 |
 |
Pitavastatin Impurity 1 |
|
|
 |
Tramadol Impurity 1 |
66170-32-9 |
C16H25NO2 |
 |
Etoricoxib Impurity 11 |
202409-31-2 |
C17H13ClN2O2S |
![methyl 3-[[4-chloro-2-(phenylamino)phenyl]methylamino]-3-oxopropanoate.](/CAS/20200119/GIF/2089061-92-5.gif) |
methyl 3-[[4-chloro-2-(phenylamino)phenyl]methylamino]-3-oxopropanoate. |
2089061-92-5 |
C17H17ClN2O3 |
 |
17,21-ジヒドロキシ-16β-メチルプレグナ-1,4,11-トリエン-3,20-ジオン |
330157-04-5 |
C22H28O4 |
 |
Dolutegravir Impurity 2 |
|
|
 |
Ornidazole Impurity 13 |
1685275-23-3 |
C7H10N3O6P.Na |
 |
Celecoxib Impurity 18 |
2271123-54-5 |
C11H9F3O2 |
 |
Rosuvastatin Impurity 158 |
|
|
 |
Vonoprazan Impurity 3 |
|
|
 |
1-(2,4-difluoro-6-hydroxyphenyl)prop-2-en-1-one |
|
|
 |
4-(2-メチルプロピル)ベンゼンエタノール |
36039-35-7 |
C12H18O |
 |
(R)-4-(2-(benzyl(methyl)amino)-1-hydroxyethyl)benzene-1,2-diol |
317351-40-9 |
C16H19NO3 |
 |
Moxifloxacin Impurity 8 |
1829588-19-3 |
C21H25N3O5 |
 |
Benzamide, 2,5-dichloro-N-(3-methylbutyl)- |
349086-08-4 |
C12H15Cl2NO |
 |
6-Oxo-Palonosetron |
848074-10-2 |
C19H22N2O2 |
 |
Exemestane impurity B -F |
184972-09-6 |
C20H26O3 |
 |
SofosBuvir Impurity 61 |
|
|
 |
Doxofylline Impurity 4 |
2095554-12-2 |
C11H16N4O5 |
 |
2,4-ビス(2-フラニルメチルアミノ)-5-スルファモイル安息香酸 |
5046-19-5 |
C17H17N3O6S |
 |
Linagliptin Impurity 42 |
|
|
 |
1,2-Benzenedicarboxylicacid,3-(hydroxyamino)-(9CI) |
202262-76-8 |
C8H7NO5 |
 |
3-(3-ヒドロキシプロピルジチオ)プロパン-1-オール |
30453-21-5 |
C6H14O2S2 |
 |
Ticagrelor Impurity 107 |
|
|
 |
Riociguat Impurtiy 2 |
|
|
 |
Ticagrelor Related Compound 54 |
|
|
 |
ジエチルカルバミン酸クロロメチル |
133217-92-2 |
C6H12ClNO2 |
 |
RAC-(CIS/TRANS) ドネペジルN-オキシド |
120013-84-5 |
C24H29NO4 |
 |
Atropine Impurity 4 |
3423-23-2 |
C17H23NO3 |
 |
Sunitinib iMpurity F |
|
|
![2'-[(1E)-2-[4-[[(2-carboxyethyl)aMino]carbonyl]phenyl]diazenyl] Balsalazide](/CAS/20140608/GIF/CB72551435.gif) |
2'-[(1E)-2-[4-[[(2-carboxyethyl)aMino]carbonyl]phenyl]diazenyl] Balsalazide |
1346606-53-8 |
C27H24N6O9 |
 |
Phosphine oxide, tris (2-methylphenyl)- |
6163-63-9 |
C21H21OP |
 |
Cabozantinib Impurity E |
|
|
 |
メトプロロール酸エチルエステル |
29112-40-1 |
C16H25NO4 |
 |
Pyrimidine, 4-chloro-5-nitro-2-(propylthio)- |
2518331-26-3 |
C7H8ClN3O2S |
 |
Lasoprazole impurity |
|
|
 |
4-メチル-1-ピペラジンカルボニルクロリド |
39539-66-7 |
C6H11ClN2O |
 |
Rivaroxaban Impurity 58 |
|
|
 |
Oxacillin USP Impurity D |
|
|
 |
Nicorandil Impurity D |
|
|
![2-[4-[(RS)-(4-Chlorophenyl)phenylMethyl]-piperazin-1-yl]ethanolDihydrochloride](/CAS/20130318/GIF/CB42617044.gif) |
2-[4-[(RS)-(4-Chlorophenyl)phenylMethyl]-piperazin-1-yl]ethanolDihydrochloride |
|
C19H25Cl3N2O |
 |
1589503-93-4 |
1589503-93-4 |
C27H24F2N6O3S |
 |
ケンペロール 3‐ロビノシド 7‐グルコシド |
114924-89-9 |
C33H40O20 |
 |
Bendamustine Impurity 33 |
|
|
 |
5a-17-(3-Pyridyl)-16-androstene-3-one |
|
C24H31NO |
 |
Moxifloxacin Impurity 34 |
1824286-08-9 |
C9H7ClF2O3 |
![1-Chloro-2-[(4-ethoxyphenyl)methyl]benzene](/CAS/20200331/GIF/1662702-90-0.gif) |
1-Chloro-2-[(4-ethoxyphenyl)methyl]benzene |
1662702-90-0 |
C15H15ClO |
 |
(Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylic acid compound with 3-benzoyl-2-oxoindoline-6-carboxylic acid |
1253768-91-0 |
C16H11NO4 |
 |
rac Des(isopropylaMino) Acebutolol Diol |
96480-91-0 |
C15H21NO5 |
 |
Erlotinib Impurity 31 |
|
|
 |
8-Hydroxy Pitavastatin |
224320-09-6 |
C25H24FNO5 |
 |
Hydrochloric acid titrantion solution c(HCl)=0.01 mol/L |
|
|
 |
SalMeterol IMpurity A |
|
C25H37NO4 |
 |
rac-NR-2501-13C2-d4 |
3029020-57-0 |
C20H20ClF5N4O2S |
 |
Agomelatine Impurity 1 |
1352139-51-5 |
C15H19NO2 |
 |
Apremilast Impurity FA |
2077897-94-8 |
C21H22N2O7S |
 |
ApovincaMinic Acid Ethyl Ester N-Oxide |
109741-24-4 |
C22H26N2O3 |
 |
ジヒドロケンペロール3-O-グルコシド |
31049-08-8 |
C21H22O11 |
 |
Vonoprazan Impurity B-3 |
|
|
 |
Amoxicillin EP Impurity C |
2088961-37-7 |
C16H19N3O5S |
![2-((6S,8S,9S,10S,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate](/CAS/20210305/GIF/114696-04-7.gif) |
2-((6S,8S,9S,10S,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate |
114696-04-7 |
C24H36O6 |
 |
(R)-3,5-dibromo-N-((1-ethylpyrrolidin-2-yl)methyl)-2,6-dimethoxybenzamide |
|
C16H22Br2N2O3 |
 |
Fondaparinux sodium impurity 16 |
|
|
 |
Flucloxacillin Impurity 2 |
|
|